CL2022001464A1 - Polimorfos del compuesto antifúngico de triazol pc945 - Google Patents
Polimorfos del compuesto antifúngico de triazol pc945Info
- Publication number
- CL2022001464A1 CL2022001464A1 CL2022001464A CL2022001464A CL2022001464A1 CL 2022001464 A1 CL2022001464 A1 CL 2022001464A1 CL 2022001464 A CL2022001464 A CL 2022001464A CL 2022001464 A CL2022001464 A CL 2022001464A CL 2022001464 A1 CL2022001464 A1 CL 2022001464A1
- Authority
- CL
- Chile
- Prior art keywords
- polymorphs
- antifungal compound
- triazole antifungal
- compound
- triazole
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 150000003852 triazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1917867.2A GB201917867D0 (en) | 2019-12-06 | 2019-12-06 | Polymorphs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2022001464A1 true CL2022001464A1 (es) | 2023-03-24 |
Family
ID=69171938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2022001464A CL2022001464A1 (es) | 2019-12-06 | 2022-06-02 | Polimorfos del compuesto antifúngico de triazol pc945 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US12491182B2 (enExample) |
| EP (2) | EP4069690B1 (enExample) |
| JP (1) | JP2023505227A (enExample) |
| KR (1) | KR20220110726A (enExample) |
| CN (1) | CN114746415B (enExample) |
| AU (1) | AU2020397613A1 (enExample) |
| BR (1) | BR112022006259A2 (enExample) |
| CA (1) | CA3155829A1 (enExample) |
| CL (1) | CL2022001464A1 (enExample) |
| CO (1) | CO2022007808A2 (enExample) |
| DK (1) | DK4069690T3 (enExample) |
| ES (1) | ES3000984T3 (enExample) |
| FI (1) | FI4069690T3 (enExample) |
| GB (1) | GB201917867D0 (enExample) |
| HR (1) | HRP20250042T1 (enExample) |
| HU (1) | HUE069799T2 (enExample) |
| IL (1) | IL293401A (enExample) |
| LT (1) | LT4069690T (enExample) |
| MX (1) | MX2022006654A (enExample) |
| PL (1) | PL4069690T3 (enExample) |
| PT (1) | PT4069690T (enExample) |
| RS (1) | RS66401B1 (enExample) |
| SA (1) | SA522432879B1 (enExample) |
| SI (1) | SI4069690T1 (enExample) |
| SM (1) | SMT202400514T1 (enExample) |
| WO (1) | WO2021111142A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2963625C (en) | 2014-12-05 | 2023-08-22 | Pulmocide Limited | 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(4-fluorophenyl)benzamide or salts thereof, and use to treat mycoses |
| CN117510488B (zh) * | 2022-07-28 | 2025-12-05 | 博瑞制药(苏州)有限公司 | 一种硫酸艾沙康唑的制备方法 |
| CN117330660A (zh) * | 2023-09-14 | 2024-01-02 | 广州医科大学附属第一医院（广州呼吸中心） | Uplc-ms/ms联用检测艾沙康唑的方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| WO1989004829A1 (en) | 1987-11-20 | 1989-06-01 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| US5039676A (en) | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| AU681753B2 (en) | 1993-12-21 | 1997-09-04 | Merck Sharp & Dohme Corp. | Tetrahydrofuran antifungals |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| AU5928096A (en) | 1995-06-02 | 1996-12-18 | Schering Corporation | Tetrahydrofuran antifungals |
| EP0957101A1 (en) | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| EP1372394A1 (en) | 2001-04-03 | 2004-01-02 | Schering Corporation | Antifungal composition with enhanced bioavailability |
| EP2141159A1 (en) * | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
| WO2013036866A1 (en) | 2011-09-07 | 2013-03-14 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| CA2963625C (en) * | 2014-12-05 | 2023-08-22 | Pulmocide Limited | 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(4-fluorophenyl)benzamide or salts thereof, and use to treat mycoses |
-
2019
- 2019-12-06 GB GBGB1917867.2A patent/GB201917867D0/en not_active Ceased
-
2020
- 2020-12-04 EP EP20824979.7A patent/EP4069690B1/en active Active
- 2020-12-04 KR KR1020227012753A patent/KR20220110726A/ko active Pending
- 2020-12-04 ES ES20824979T patent/ES3000984T3/es active Active
- 2020-12-04 LT LTEPPCT/GB2020/053107T patent/LT4069690T/lt unknown
- 2020-12-04 CN CN202080082529.6A patent/CN114746415B/zh active Active
- 2020-12-04 PT PT208249797T patent/PT4069690T/pt unknown
- 2020-12-04 JP JP2022533459A patent/JP2023505227A/ja active Pending
- 2020-12-04 HR HRP20250042TT patent/HRP20250042T1/hr unknown
- 2020-12-04 FI FIEP20824979.7T patent/FI4069690T3/fi active
- 2020-12-04 SI SI202030565T patent/SI4069690T1/sl unknown
- 2020-12-04 CA CA3155829A patent/CA3155829A1/en active Pending
- 2020-12-04 EP EP24212504.5A patent/EP4509179A3/en active Pending
- 2020-12-04 RS RS20250045A patent/RS66401B1/sr unknown
- 2020-12-04 MX MX2022006654A patent/MX2022006654A/es unknown
- 2020-12-04 US US17/782,232 patent/US12491182B2/en active Active
- 2020-12-04 BR BR112022006259A patent/BR112022006259A2/pt unknown
- 2020-12-04 AU AU2020397613A patent/AU2020397613A1/en active Pending
- 2020-12-04 WO PCT/GB2020/053107 patent/WO2021111142A1/en not_active Ceased
- 2020-12-04 SM SM20240514T patent/SMT202400514T1/it unknown
- 2020-12-04 DK DK20824979.7T patent/DK4069690T3/da active
- 2020-12-04 PL PL20824979.7T patent/PL4069690T3/pl unknown
- 2020-12-04 HU HUE20824979A patent/HUE069799T2/hu unknown
- 2020-12-04 IL IL293401A patent/IL293401A/en unknown
-
2022
- 2022-06-01 CO CONC2022/0007808A patent/CO2022007808A2/es unknown
- 2022-06-02 CL CL2022001464A patent/CL2022001464A1/es unknown
- 2022-06-05 SA SA522432879A patent/SA522432879B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SA522432879B1 (ar) | 2025-01-26 |
| WO2021111142A1 (en) | 2021-06-10 |
| US12491182B2 (en) | 2025-12-09 |
| EP4509179A3 (en) | 2025-02-26 |
| HUE069799T2 (hu) | 2025-04-28 |
| AU2020397613A1 (en) | 2022-06-02 |
| JP2023505227A (ja) | 2023-02-08 |
| CN114746415A (zh) | 2022-07-12 |
| IL293401A (en) | 2022-07-01 |
| LT4069690T (lt) | 2025-01-10 |
| US20230028714A1 (en) | 2023-01-26 |
| BR112022006259A2 (pt) | 2022-06-21 |
| SI4069690T1 (sl) | 2025-03-31 |
| PT4069690T (pt) | 2024-12-13 |
| RS66401B1 (sr) | 2025-02-28 |
| KR20220110726A (ko) | 2022-08-09 |
| GB201917867D0 (en) | 2020-01-22 |
| DK4069690T3 (da) | 2025-01-20 |
| CO2022007808A2 (es) | 2022-06-30 |
| ES3000984T3 (es) | 2025-03-04 |
| MX2022006654A (es) | 2022-09-07 |
| EP4069690B1 (en) | 2024-11-13 |
| SMT202400514T1 (it) | 2025-01-14 |
| HRP20250042T1 (hr) | 2025-03-14 |
| EP4069690A1 (en) | 2022-10-12 |
| PL4069690T3 (pl) | 2025-03-10 |
| FI4069690T3 (fi) | 2025-01-21 |
| CN114746415B (zh) | 2025-04-11 |
| EP4509179A2 (en) | 2025-02-19 |
| CA3155829A1 (en) | 2021-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022001464A1 (es) | Polimorfos del compuesto antifúngico de triazol pc945 | |
| MX2020005323A (es) | Triazol azinas de acido ciclohexilo como antagonistas de acido lisofosfatidico (lpa). | |
| CL2020001547A1 (es) | Carbamoíl ciclohexil ácidos ligados a n de triazol como antagonistas de lpa. | |
| MX381205B (es) | Acidos de carbamoiloximetil triazol ciclohexilo como antagonistas de acido lisofosfatidico (lpa). | |
| IL320185A (en) | Heterocyclic compound | |
| EP4037687A4 (en) | BENZOXAZINONE COMPOUNDS AS DUAL KLK5/7 INHIBITORS | |
| CL2021000454A1 (es) | Método para preparar 2-[(3r)-3--metilmofolin--4-il]-4-(1-metil-1h-pirazol-5-il)-8-(1h-pirazol-5-il)-1,7-naftiridina | |
| PH12017501404A1 (en) | Diaza-benzofluoranthrene compounds | |
| GB202202921D0 (en) | Novel compounds | |
| MX2024011757A (es) | Proceso para preparar compuestos de acido carbamoiloximetil triazol ciclohexilico | |
| GB202302686D0 (en) | Novel compounds | |
| GB202300833D0 (en) | Novel compounds | |
| ZA202408061B (en) | Benzotriazole compound | |
| GB202304448D0 (en) | Novel compounds | |
| GB202302534D0 (en) | Novel compounds | |
| GB202301448D0 (en) | Novel compounds | |
| GB202218818D0 (en) | Novel compounds | |
| GB202217864D0 (en) | Novel compounds | |
| GB202217862D0 (en) | Novel compounds | |
| GB202217863D0 (en) | Novel compounds | |
| GB202217865D0 (en) | Novel compounds | |
| GB202217866D0 (en) | Novel compounds | |
| GB202217575D0 (en) | Novel compounds | |
| GB202216962D0 (en) | Novel compounds | |
| GB202216963D0 (en) | Novel compounds |